Biocryst Pharmaceuticals (BCRX) EBITDA Margin Growth (5y) (2015 - 2026)
Biocryst Pharmaceuticals (BCRX) EBITDA Margin Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Biocryst Pharmaceuticals | 2.02 Bn | 1.78 Bn | 151.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12,539.00 |
| Dec 31, 2025 | 3.61 Mn |
| Sep 30, 2025 | 76,341.00 |
| Jun 30, 2025 | 134,853.00 |
| Mar 31, 2025 | 78,026.00 |
| Dec 31, 2024 | -1,476.00 |
| Sep 30, 2024 | 210,629.00 |
| Jun 30, 2024 | 257,792.00 |
| Mar 31, 2024 | 48,522.00 |
| Dec 31, 2023 | 93,555.00 |
| Sep 30, 2023 | 199,112.00 |
| Jun 30, 2023 | 5,626.00 |
| Mar 31, 2023 | 57,744.00 |
| Dec 31, 2022 | 41,842.00 |
| Sep 30, 2022 | 11,656.00 |
| Jun 30, 2022 | 45,519.00 |
| Mar 31, 2022 | 197.00 |
| Dec 31, 2021 | 1,294.00 |
| Sep 30, 2021 | 544.00 |
| Jun 30, 2021 | 25,349.00 |